U.S. Medical Devices Reimbursement Market Size & Outlook
Related Markets
U.S. medical devices reimbursement market highlights
- The U.S. medical devices reimbursement market generated a revenue of USD 333,666.1 million in 2024 and is expected to reach USD 528,000.0 million by 2030.
- The U.S. market is expected to grow at a CAGR of 7.9% from 2025 to 2030.
- In terms of segment, underpaid was the largest revenue generating claim in 2024.
- Underpaid is the most lucrative claim segment registering the fastest growth during the forecast period.
Medical devices reimbursement market data book summary
| Market revenue in 2024 | USD 333,666.1 million |
| Market revenue in 2030 | USD 528,000.0 million |
| Growth rate | 7.9% (CAGR from 2025 to 2030) |
| Largest segment | Underpaid |
| Fastest growing segment | Underpaid |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Underpaid, Full Paid |
| Key market players worldwide | Aviva PLC, CVS Health Corp, BNP Paribas Act. Cat.A, Allianz SE, Humana Inc, The Cigna Group, UnitedHealth Group Inc, Nippon Life Insurance Company of Japan, WellCare Health Plans, Elevance Health |
Other key industry trends
- In terms of revenue, U.S. accounted for 42.9% of the global medical devices reimbursement market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. medical devices reimbursement market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 528,000.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Medical Devices Reimbursement Market Scope
Medical Devices Reimbursement Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Elevance Health | View profile | 10001+ | Indianapolis, Indiana, United States, North America | https://www.elevancehealth.com |
| WellCare Health Plans | View profile | 5001-10000 | Tampa, Florida, United States, North America | https://www.wellcare.com/en/florida |
| Nippon Life Insurance Company of Japan | View profile | 10001+ | Osaka, Osaka, Japan, Asia | http://www.nissay.co.jp/ |
| Humana Inc | View profile | 67600 | 500 West Main Street, Louisville, KY, United States, 40202 | https://www.humana.com |
| BNP Paribas Act. Cat.A | View profile | 182656 | 16, Boulevard Des Italiens, Paris, France, 75009 | https://group.bnpparibas |
| Aviva PLC | View profile | 23247 | St Helen's, 1 Undershaft, London, United Kingdom, EC3P 3DQ | https://www.aviva.com |
| CVS Health Corp | View profile | 300000 | One CVS Drive, Woonsocket, RI, United States, 02895 | https://www.cvshealth.com |
| The Cigna Group | View profile | 72500 | 900 Cottage Grove Road, Bloomfield, CT, United States, 06002 | https://www.cigna.com |
| UnitedHealth Group Inc | View profile | 440000 | 9900 Bren Road East, UnitedHealth Group Center, Minnetonka, MN, United States, 55343 | https://www.unitedhealthgroup.com |
| Allianz SE | View profile | 154862 | Koniginstrasse 28, Munich, BY, Germany, 80802 | https://www.allianz.com |
U.S. medical devices reimbursement market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical devices reimbursement market will help companies and investors design strategic landscapes.
Underpaid was the largest segment with a revenue share of 87.89% in 2024. Horizon Databook has segmented the U.S. medical devices reimbursement market based on underpaid, full paid covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. accounted for the largest share of 93.87% in North America due to technological advancements and the recent reimbursement approvals of many medical devices. The U.S. Affordable Care Act helps regulate and reduce healthcare expenses by distributing the cost of specific services across a broad patient base.
This legislation has made healthcare more accessible to a larger population by promoting innovative approaches to delivering medical care at lower costs. In addition, the Centers for Medicare & Medicaid Services (CMS) implements effective strategies to enhance the healthcare system by ensuring the provision of high-quality, reliable care and expanding health insurance coverage nationwide. These supportive policies contribute significantly to the dominant share of the medical device reimbursement market.
Reasons to subscribe to U.S. medical devices reimbursement market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. medical devices reimbursement market databook
-
Our clientele includes a mix of medical devices reimbursement market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. medical devices reimbursement market , including forecasts for subscribers. This country databook contains high-level insights into U.S. medical devices reimbursement market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. medical devices reimbursement market size, by claim, 2018-2030 (US$M)
U.S. Medical Devices Reimbursement Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
